Corrigendum to “Hepatitis B birth dose vaccination for newborns in Uganda: A qualitative inquiry on pregnant women's perceptions, barriers and preferences” [J Virus Eradic 7(2) (2021) 100039]

Some African countries are still reluctant to introduce the hepatitis B vaccine birth dose (HepB-BD) into their expanded program of immunization (EPI), partly because of logistical, economic, and cost information constraints. To assist decision-makers in these countries, we assessed the economic and financial costs of HepB-BD introduction in Senegal in 2016. We performed a micro-costing study in a representative sample of Senegal’s EPI sites at all levels in 2018. Information on EPI and HepB-BD activity-related inputs and costs was collected using standardized questionnaires and semi-structured interviews. Using inverse probability weighting, we computed weighted average costs associated with HepB-BD introduction for each EPI level, country-level aggregated costs and estimated costs per newborn. Economic and financial costs from a government perspective were estimated in US dollars for 2015, 2016 and 2017. Total economic costs were USD 143,364 in 2015, USD 759,406 in 2016 and USD 867,311 in 2017, while financial costs were USD 127,745, USD 82,519 and USD 29,853, respectively. When annualizing pre-introduction and initial training costs, the economic (financial) cost per vaccinated newborn was USD 2.10 (USD 0.30) in 2016 and USD 1.90 (USD 0.20) in 2017. Our estimates provide valuable information to implement HepB-BD in Sub-Saharan African countries that have not yet integrated this vaccine.

Download Full-text

Hepatitis B Vaccination of Low Birth Weight Infants in Washington State

American Journal of Perinatology ◽

10.1055/s-0040-1721372 ◽

2020 ◽

Author(s):

Katarina Ost ◽

Natalia V. Oster ◽

Elizabeth N. Jacobson ◽

M. Patricia deHart ◽

Janet A. Englund ◽

...

Keyword(s):

Birth Weight ◽

Hepatitis B ◽

Low Birth Weight ◽

Academic Medical Center ◽

Washington State ◽

Hepatitis B Vaccination ◽

High Risk Population ◽

Low Birth Weight Infants ◽

Birth Dose ◽

Birth Hospitalization

Objective The U.S. Advisory Committee on Immunization Practices (ACIP) recommends that infants born weighing less than 2,000 g receive the hepatitis B (HepB) vaccine at hospital discharge or 30 days of age. This study aimed to assess timely HepB vaccination among low birth weight infants. We hypothesized that many of these vulnerable infants would fail to receive their HepB birth dose on time. Study Design This retrospective cohort study included Washington State infants born weighing less than 2,000 g at an academic medical center between 2008 and 2013. Data were abstracted from electronic health records and linked to vaccine data from the Washington State Immunization Information System. Multivariable logistic regression was used to examine the associations between sociodemographic, clinical, and visit characteristics and HepB vaccination by birth hospitalization discharge or 30 days of age. Results Among 976 study infants, 58.4% received their HepB vaccine by birth hospitalization discharge or 30 days of age. Infants had higher odds of timely HepB vaccination if they were Hispanic (adjusted odds ratio [AOR] = 1.80, 95% confidence interval [CI]: 1.10–2.95) or non-Hispanic black (AOR = 2.28, 95% CI: 1.36–3.80) versus non-Hispanic white or if they were hospitalized 14 days or longer versus less than 14 days (AOR = 2.43, 95% CI: 1.66–3.54). Infants had lower odds of timely HepB vaccination if they were born before 34 weeks versus on or after 34 weeks of gestational age (AOR = 0.41, 95% CI: 0.27–0.63) or if they had an estimated household income less than $50,845 versus 50,845 or greater (AOR = 0.64, 95% CI: 0.48–0.86). Conclusion Many infants born weighing less than 2,000 g did not receive their first HepB birth dose according to ACIP recommendations. Strategies are needed to improve timely HepB vaccination in this high-risk population. Key Points

Download Full-text

Developing an Evidence Base for the Delivery of Hepatitis B Virus Birth Dose Vaccination: An Evidence Map and Critical Appraisal of Systematic Reviews and Guidelines

Clinical Liver Disease ◽

10.1002/cld.1103 ◽

2021 ◽

Vol 17 (5) ◽

pp. 375-381

Author(s):

Stephanie Doran Brubaker ◽

John W. Ward ◽

Lindsey Hiebert ◽

Rebecca L. Morgan

Keyword(s):

Hepatitis B Virus ◽

Hepatitis B ◽

Systematic Reviews ◽

Critical Appraisal ◽

Evidence Base ◽

Evidence Map ◽

B Virus ◽

Birth Dose

Download Full-text

‘Every medicine is part poison’: a qualitative inquiry into the perceptions and experiences of choosing contraceptive methods of migrant Chinese women living in Australia

BMC Women s Health ◽

10.1186/s12905-021-01226-3 ◽

2021 ◽

Vol 21 (1) ◽

Author(s):

Hankiz Dolan ◽

Mu Li ◽

Deborah Bateson ◽

Rachel Thompson ◽

Chun Wah Michael Tam ◽

...

Keyword(s):

Decision Making ◽

Contraceptive Method ◽

Intrauterine Device ◽

Qualitative Inquiry ◽

Medical Advice ◽

The Body ◽

Hormonal Contraceptives ◽

Contraceptive Methods ◽

Structured Interviews ◽

Women’S Perceptions

Abstract Background In Australia, ethnic Chinese people are one of the largest, youngest and fastest growing overseas-born groups. Yet, little is known about their perceptions of contraceptive methods and their experiences with choosing one. Decisions about contraceptive methods are preference sensitive. Understanding the influencing factors of Chinese migrant women’s contraceptive method choice and practices will help cater to their decision-making needs in a culturally sensitive and responsive way. Methods A qualitative study design underpinned by critical realism approach was used to explore Chinese migrant women’s perceptions and experiences of choosing contraceptive methods. Semi-structured interviews were conducted with 22 women who self-identified as being ethnically Chinese and had been living in Australia for no more than 10 years. The interview guide was adapted from the Ottawa Decision Support Framework. Majority of the interviews were conducted in Mandarin Chinese. Transcribed data was analysed using thematic analysis method. Results Four major themes were identified, including: ‘every medicine is part poison: hormonal contraceptives cause harm to the body’; ‘intrauterine device, a device used in the past for married women’; ‘it takes two (or one) to decide, depending on the relationship dynamics and contraception preferences’; and ‘it is not necessary to seek medical advice in choosing contraceptive methods’. Conclusions Our findings suggest that Chinese migrant women’s perceptions and experiences of choosing contraceptive methods are influenced by complex personal, cultural, societal and inter-relational factors. Chinese migrant women were cautious of using hormonal methods due to fears of side-effects, including reduced or absent menstrual bleeding. Women were also reluctant to consider intrauterine devices as options due to associating them with past experiences of other women and themselves and also fears of potential complications. There was a reluctant attitude towards seeking medical advice regarding contraception due to beliefs that needing to use contraception is not an illness requiring treatment. Such findings are likely to be useful in increasing healthcare professionals’ and policy makers’ understanding of Chinese migrant women’s contraceptive method preferences, beliefs and behaviours. They also help to develop culturally and linguistically sensitive strategies, which goes beyond the provision of contraceptive counselling, in assisting Chinese migrant women’s decision-making needs.

Download Full-text

Implementing a national policy for hepatitis B birth dose vaccination in Philippines: Lessons for improved delivery

Vaccine ◽

10.1016/j.vaccine.2010.11.047 ◽

2011 ◽

Vol 29 (5) ◽

pp. 941-945 ◽

Cited By ~ 14

Author(s):

Howard L. Sobel ◽

Jacinto Blas Mantaring ◽

Francisca Cuevas ◽

Joyce V. Ducusin ◽

Margaret Thorley ◽

...

Keyword(s):

Hepatitis B ◽

National Policy ◽

Birth Dose

Download Full-text

Arresting Vertical Transmission of Hepatitis B Virus (AVERT-HBV) in the Democratic Republic of the Congo

10.1101/2021.03.19.21253929 ◽

2021 ◽

Author(s):

Peyton Thompson ◽

Camille E. Morgan ◽

Patrick Ngimbi ◽

Kashamuka Mwandagalirwa ◽

Noro Ravelomanana ◽

...

Keyword(s):

Hepatitis B Virus ◽

Hepatitis B ◽

Pregnant Women ◽

Democratic Republic ◽

Sub Saharan Africa ◽

Pmtct Program ◽

B Virus ◽

Birth Dose ◽

Republic Of The Congo ◽

Dose Vaccine

Background: Hepatitis B virus (HBV) remains endemic throughout sub-Saharan Africa despite the widespread availability of effective vaccines. We evaluated the feasibility of adding HBV testing and treatment of pregnant women and birth-dose vaccination of HBV-exposed infants to the HIV prevention of MTCT (PMTCT) program infrastructure in the Democratic Republic of the Congo (DRC), where HBV treatment and birth-dose vaccination programs are not established. Methods: As part of the HIV PMTCT program at two maternity centers in Kinshasa, DRC, pregnant women were screened for HBV at routine prenatal care registration. Pregnant women with high viral load and/or HBeAg positivity were offered tenofovir disoproxil fumarate (TDF). HBV-exposed infants received a birth-dose of HBV vaccine within 24 hours of life. The primary endpoint was the feasibility and acceptability of the study. Results: Of 4,016 women screened, 109 (2.7%) were HBsAg-positive. Ten of 91 (11.1%) women evaluated had high-risk disease. Of 88 infants, 60 (68.2%) received a birth-dose vaccine; of these, 46 (76.7%) received a timely birth-dose. No cases of HBV MTCT were observed in our cohort. There were no serious adverse events associated with TDF nor with birth-dose vaccine. The study procedures were highly acceptable (>80%) among mothers. Conclusions: Adding HBV screening and treatment of pregnant women and infant birth-dose vaccination to existing HIV PMTCT platforms is feasible in countries like the DRC. Birth-dose vaccination against HBV integrated within the current Expanded Programme on Immunization (EPI) and HIV PMTCT program could accelerate progress toward HBV elimination in Africa.

Download Full-text

Improved timely birth dose coverage of hepatitis B vaccine narrows the socio-economic inequality in western China in 2011–2016

Vaccine ◽

10.1016/j.vaccine.2018.05.085 ◽

2018 ◽

Vol 36 (27) ◽

pp. 3901-3907 ◽

Cited By ~ 4

Author(s):

Xiaoli Liu ◽

Chenlu Yang ◽

Qiuyue Zhong ◽

Qiying Song ◽

Xiaona Huang ◽

...

Keyword(s):

Hepatitis B ◽

Economic Inequality ◽

Hepatitis B Vaccine ◽

Western China ◽

Birth Dose

Download Full-text

Coverage of hepatitis B vaccine birth dose in Vietnam during 2014-2018

Tạp chí Y học Dự phòng ◽

10.51403/0868-2836/2020/254 ◽

2021 ◽

Vol 30 (4) ◽

pp. 86-92

Author(s):

Vu Hai Ha ◽

Dao Trung Nguyen ◽

Ngo Thi Thanh Van ◽

Pham Dinh Long ◽

Pham Quang Thai

Keyword(s):

Hepatitis B ◽

Cross Sectional Study ◽

Hepatitis B Vaccine ◽

Mekong River ◽

Sectional Study ◽

Mountain Area ◽

Cross Sectional ◽

Delta Area ◽

Mekong River Delta ◽

Birth Dose

A cross-sectional study in 63 provinces/cities in Vietnam (2014-2018) was conducted to describe the coverage of hepatitis B vaccine birth dose from 2014-2018 in Vietnam. The results showed that the coverage proportion of Hepatitis B vaccine birth dose (hepB-BD) in Vietnam during 2014-2018 was 73.4%, of which the proportion of hepB-BD with in 24 hours and after 24 hours of births were 68.7% and 4.7%, respectively. There was diffirent between socio-economic areas (p<0.01). The proportions of hepB-BD in Mekong River Delta area and in Northern midlands and mountain area were highest (81.7%) and lowest (57.2%), respectively. The coverage proportion of hepB-BD in Vietnam during 2014-2018 was low, varied unevenly between years and regions/areas. Enhancing the coverage of hepB-BD, especially hepB-BD vaccination within 24 hours of births will be highly recommended.

Download Full-text